Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects

Completed

Conditions studied: Covid19

In brief

Prospective samples will be collected to evaluate the agreement between a EUA RT-PCR test as the comparator method against the Nanomix eLab® system.

Key facts

Study ID

NCT04667442

Run by

Nanomix

People needed

137

Starts

2020-12-01

Expected to finish

2021-12-14

Last updated by the study team

2021-12-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18 years of age or older
• Male or Female
• Willing and able to provide informed consent
• Symptomatic or asymptomatic
• The EUA RT-PCR sample must be collected within one (1) day of the sample collected for testing by the Nanomix eLab® COVID-19 Rapid Antigen Panel.

You may not qualify if…

• Subjects without both a valid EUA RT-PCR test result and a valid Nanomix eLab® COVID-19 Rapid Antigen results will be excluded
• Subjects not being able to provide consent

Where it is running

• Nanomix — Emeryville, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.